Increased expression of ECT2 predicts the poor prognosis of breast cancer patients.
Journal Information
Full Title: Exp Hematol Oncol
Abbreviation: Exp Hematol Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"availability of data and materials the tcga datasets for this study can be found in the https://xenabrowser net/datapages/ . the gse25066"
"Declarations Ethics approval and consent to participateThis study was approved by the ethics committee of the Tongji Hospital of Huazhong University of Science and Technology. Consent for publicationNot applicable. Competing interestsThe authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. As the editorial board member of Experimental Hematology & Oncology, KW decleare that he has no competing interests and is excluded from the peer review process. This submission is not given any priority over other manuscripts, and editorial board member status has no bearing on editorial consideration. Competing interests The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. As the editorial board member of Experimental Hematology & Oncology, KW decleare that he has no competing interests and is excluded from the peer review process. This submission is not given any priority over other manuscripts, and editorial board member status has no bearing on editorial consideration."
"Funding This work was supported by the National Natural Science Foundation of China (Nos. 81874120 and 82272794)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025